Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 2;7(3):252-66.
doi: 10.1080/21505594.2016.1159366.

Epidemiology of antimicrobial resistance in bloodstream infections

Affiliations
Review

Epidemiology of antimicrobial resistance in bloodstream infections

Murat Akova. Virulence. .

Abstract

Antimicrobial resistance in bacterial pathogens is a worldwide challenge leading high morbidity and mortality in clinical settings. Multidrug resistant patterns in gram-positive and -negative bacteria have resulted in difficult-to-treat or even untreatable infections with conventional antimicrobials. Since the early identification of causative microorganisms and their antimicrobial susceptibility patterns in patients with bacteremia and other serious infections is lacking in many healthcare institutions, broad spectrum antibiotics are liberally and mostly unnecessarily used. Such practice has, in turn, caused dramatic increases in emerging resistance and when coupled with poor practice of infection control, resistant bacteria can easily be disseminated to the other patients and the environment. Thus, availability of updated epidemiological data on antimicrobial resistance in frequently encountered bacterial pathogens will be useful not only for deciding on empirical treatment strategies, but also devising an effective antimicrobial stewardship program in hospitals.

Keywords: antimicrobial resistance; antimicrobial stewardship; bloodstream infection; multidrug resistance.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Data shown on the graph are obtained from the following sources: Australia: Australian Group on Antimicrobial Resistance (AGAR). Available at http://www.agargroup.org, France, Germany, Greece, UK: European Antimicrobial Resistance Surveillance Network (EARS Net). Available at http://www.ersnet.org, Turkey: The data for the period of 2003–2008 are derived from EARSS European Antimicrobial Resistance Surveillance System (EARSS) available at http://www.rivm.nl. For 2009–2010; personal communication with Dolunay Gulmez, M.D. For 2011–2013; from National Antimicrobial Resistance Surveillance System Yearly Reports 2011–2013. Turkish Public Health Insititution. Available at http://uamdss.thsk.gov.tr, USA: Resistance Map-The Center for Disease Dynamics Economics & Policy (CDDEP) . Available at: http://resistancemap.cddep.org.

References

    1. Centers for Disease Control and Prevention (CDC) Antibiotic resistance threats in the United States. 2013. Available at http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013...
    1. O'Neill J. (chair). Review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Available at http://amr-review.org/
    1. Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15:1429-37; PMID:26482597; http://dx.doi.org/10.1016/S1473-3099(15)00270-4 - DOI - PubMed
    1. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197:1079-81; PMID:18419525; http://dx.doi.org/10.1086/533452 - DOI - PubMed
    1. Peterson LR. Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis 2009; 49:992; PMID:19694542; http://dx.doi.org/10.1086/605539 - DOI - PubMed

MeSH terms

Substances